Akèy › Skleroz an milti pwogresif kwonik › Georgia
Etid klinik pou Skleroz an milti pwogresif kwonik nan Georgia
3 etid pou Skleroz an milti pwogresif kwonik ap chèche patisipan nan sit nan Georgia.
Tèks ofisyèl etid la (Anglè)
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Atlanta Neuroscience Institute, Atlanta
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07609719A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 102, Atlanta
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07840326A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Joi Life Wellness Group LLC, Smyrna
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.